Table 1.
Significant eQTL identified.
| Interval | Chr | Position Mb Start-Enda,b | Size (Mb) | SNP Start | SNP End | No. SNPsc | Associated Gene | Type of eQTL |
|---|---|---|---|---|---|---|---|---|
| I1 | 2 | 134.99 | ASGA0093797 | 1 | ACSM5 | trans | ||
| I2 | 3 | 16.47–63.25 | 46.78 | ASGA0089930 | ALGA0111911 | 133 | ACSM5 | cis/trans |
| I3 | 3 | 83.37 | MARC0032158 | 1 | ACSM5 | trans | ||
| I4 | 3 | 100.91–101.46 | 0.55 | ALGA0020206 | ASGA0098441 | 3 | ACSM5 | trans |
| I5 | 10 | 0.05–0.20 | 0.15 | H3GA0055101 | ASGA0095156 | 8 | ACSM5 | trans |
| I6 | 16 | 19.13 | ALGA0089402 | 1 | ACSM5 | trans | ||
| I7 | 13 | 6.89 | ASGA0055780 | 1 | ELOVL6 | trans | ||
| I8 | 2 | 6.10–9.00 | 2.90 | ASGA0008719 | MARC0018949 | 2 | FABP4 | trans |
| I9 | 3 | 109.40–119.74 | 10.34 | ASGA0015643 | ASGA0016181 | 3 | FABP4 | trans |
| I10 | 4 | 36.73 | ALGA0024527 | 1 | FABP4 | trans | ||
| I11 | 4 | 60.57–65.25 | 4.68 | ALGA0025158 | ALGA0025337 | 5 | FABP4 | cis (FABP5)d |
| I12 | 9 | 129.18 | ALGA0054847 | 1 | FABP4 | trans | ||
| I13 | 2 | 7.85–9.22 | 1.37 | ASGA0008845 | ASGA0008874 | 8 | FADS2 | cis |
| I14 | 6 | 74.42 | ALGA0035721 | 1 | FADS2 | trans | ||
| I15 | 8 | 59.00–68.68 | 9.68 | ASGA0100508 | H3GA0024926 | 3 | FADS2 | trans |
| I16 | 10 | 46.93 | H3GA0030086 | 1 | FADS2 | trans | ||
| I17 | 9 | 20.18–20.20 | 0.02 | MARC0034587 | ASGA0041925 | 2 | SLC27A4 | trans |
| I18 | 14 | 88.90–92.43 | 3.53 | ASGA0064787 | ALGA0079407 | 16 | SLC27A4 | trans |
| I19 | 15 | 137.05–137.37 | 0.32 | ASGA0070790 | MARC0050960 | 2 | SLC27A4 | trans |
aChromosomal location is given according to Sscrofa10.2 assembly coordinates.
bGene annotation was performed including one additional Mb at the start and at the end of the trans eQTL regions. For the cis eQTLs only the analyzed gene was considered.
cNumber of significant SNPs within the eQTL interval.
dThe known mapped FABP5 gene (SSC4: 60.31 Mb) was used in order to define cis/trans eQTLs for the unmapped FABP4 gene.